Name: NEURONETICS INC (STIM) Stock
Brand: NEURONETICS INC
Rating: 4 (3 reviews)

STIM Latest News, Press Relases and Analysis

All

Press Releases

11 days ago - By: Chartmill - Mentions: CYD HTZ DENN NSP ...

Tuesday's pre-market session: top gainers and losers

11 days ago - By: Chartmill

NEURONETICS INC (NASDAQ:STIM) Stock Plummets 22% on Q3 2025 Revenue Miss

3 days ago - By: Neuronetics

TRICARE West Expands NeuroStar® TMS Coverage to Include Adolescents Aged 15+ Struggling with Depression

3 days ago - By: Neuronetics

TRICARE West Expands NeuroStar® TMS Coverage to Include Adolescents Aged 15+ Struggling with Depression

11 days ago - By: Zacks Investment Research - Mentions: SINT

Neuronetics (STIM) Reports Q3 Loss, Misses Revenue Estimates

11 days ago - By: Neuronetics

Neuronetics Reports Third Quarter 2025 Financial and Operating Results and Announces CEO Transition Plan

11 days ago - By: Benzinga - Mentions: KURA SEE HRMY FOLD ...

Earnings Scheduled For November 4, 2025

15 days ago - By: Neuronetics

Neuronetics Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

16 days ago - By: Neuronetics

Neuronetics Announces Three-Year Exclusive Partnership with Elite DNA Behavioral Health to Expand NeuroStar Access and Operational Excellence

16 days ago - By: Neuronetics

Neuronetics Announces Three-Year Exclusive Partnership with Elite DNA Behavioral Health to Expand NeuroStar Access and Operational Excellence

25 days ago - By: Neuronetics

Neuronetics to Report Third Quarter 2025 Financial and Operating Results and Host Conference Call

2 months ago - By: Neuronetics

New York State Medicaid Expands Coverage for TMS Therapy, Including NeuroStar® Advanced Therapy, to Treat Major Depressive Disorder (MDD)

2 months ago - By: Neuronetics

New York State Medicaid Expands Coverage for TMS Therapy, Including NeuroStar® Advanced Therapy, to Treat Major Depressive Disorder (MDD)

3 months ago - By: Neuronetics

Neuronetics Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

3 months ago - By: Zacks Investment Research - Mentions: TNDM

Neuronetics (STIM) Reports Q2 Loss, Tops Revenue Estimates

3 months ago - By: Neuronetics

Neuronetics Reports Second Quarter 2025 Financial and Operating Results

3 months ago - By: Benzinga - Mentions: AFG CXDO YUM PACK ...

Earnings Scheduled For August 5, 2025

3 months ago - By: Neuronetics

Neuronetics to Present at the Canaccord Genuity 45th Annual Growth Conference

4 months ago - By: Neuronetics

NeuroStar Announces New Publication in JAACAP Open Highlighting Treatment Efficacy in Depressed Adolescents

4 months ago - By: Neuronetics

NeuroStar Announces New Publication in JAACAP Open Highlighting Treatment Efficacy in Depressed Adolescents

4 months ago - By: Neuronetics

Neuronetics to Report Second Quarter 2025 Financial and Operating Results and Host Conference Call

4 months ago - By: Neuronetics

Neuronetics Appoints New Chief Financial Officer

4 months ago - By: Yahoo Finance

Neuronetics Showcases NeuroStar TMS Data at Clinical TMS Meeting

5 months ago - By: Neuronetics

Neuronetics Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

5 months ago - By: Neuronetics